FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

The FDA approved a supplemental application for NICORETTE (nicotine polacrilex) from Haleon US Holdings LLC, authorizing changes under an existing NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• NICORETTE (Nicotine polacrilex)

Snippet

SUPPL AP for NICORETTE (NICOTINE POLACRILEX)